Nurse AMIE: Addressing Metastatic Individuals Everyday (NurseAMIE)
Metastatic Breast Cancer
About this trial
This is an interventional supportive care trial for Metastatic Breast Cancer focused on measuring Exercise, Feasibility, Acceptability, Supportive Care Platform
Eligibility Criteria
Inclusion Criteria:
- Women with metastatic breast cancer
- ECOG performance score ≤3.
- English Speaking
- With sufficient vision/hearing or family support
- Willingness to be randomized
Exclusion Criteria:
- Medical or psychiatric conditions (beyond breast cancer, its treatment, and its symptoms) that would impair our ability to test study hypotheses (e. g. psychotic disorders, dementia, inability to give informed consent or follow the instruction).
- Patients who are receiving any other behavioral intervention
Sites / Locations
- Penn State Cancer Institute
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Immediate Intervention
Delayed Intervention
The immediate intervention group will receive the intervention at the time of consent (baseline) and will be enrolled in the intervention for a total of 6 months. Patients will receive the tablet, a pedometer and an exercise band. Patients will use Nurse AMIE while receiving weekly phone calls from a patient navigator. After 90 days of the intervention observation will take place for 90 days, the patient will be asked to continue using Nurse AMIE without a patient navigator's presence.
The delayed intervention group will receive the intervention 3 months after consent (6 months of intervention with 3 months delay total of 9 months); the patient will then follow the same pattern as listed above. The only difference is we will ask the delayed intervention group to wear a FitBit device for 1 week following consent in order to gain baseline data as to their activity/movement.